Valuation: RaySearch Laboratories AB

Market Cap 6.53B 655M 585M 544M 495M 931M 62.08B 947M 2.56B 32.39B 2.46B 2.41B 104B P/E 2026 *
24.9x
P/E 2027 * 20x
Enterprise Value 6.7B 672M 600M 558M 507M 954M 63.66B 971M 2.62B 33.22B 2.52B 2.47B 106B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.07x
Free-Float
80.09%
Yield 2026 *
2.06%
Yield 2027 * 2.32%
1 day+0.62%
1 week+4.86%
Current month+3.90%
1 month+11.80%
3 months-12.95%
6 months-11.60%
Current year-14.78%
1 week 190.7
Extreme 190.7
198.4
1 month 167.1
Extreme 167.1
198.4
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
264.5
3 years 78.8
Extreme 78.8
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 31/12/1999
Director of Finance/CFO 48 26/01/2025
Chief Tech/Sci/R&D Officer 53 27/08/2015
Director TitleAgeSince
Director/Board Member 57 31/12/1999
Chairman 81 17/11/2016
Chairman 87 29/09/2022
Date Insider Type Main position Quantity % Market Cap. Importance
18/08/26 Sell

Chief Technology Officer

-3,203 0.0104%
17/08/26 Sell

Chief Technology Officer

-2,297 0.0075%
11/06/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.62%+4.86%-17.32%+123.85% 655M
+3.46%+6.83%+31.94%+44.25% 258B
+3.03%+6.46%+12.32%+10.54% 163B
+1.81%+3.00%-1.78%+56.64% 151B
+2.65%+5.00%-54.83%-10.86% 63.97B
+1.91%+4.58%+20.80%+24.47% 50.78B
+1.95%+6.77%-13.31%-14.04% 50.94B
+0.89%+4.39%+25.71%+58.85% 49.49B
+5.27%+9.90%+8.93%+44.85% 50.68B
+1.73%+3.50%+33.62%+75.82% 43.64B
Average +1.98%+4.68%+4.61%+41.44% 88.16B
Weighted average by Cap. +2.33%+4.04%+11.36%+34.12%

Financials

2026 *2027 *
Net sales 1.38B 139M 124M 115M 105M 197M 13.14B 201M 541M 6.86B 521M 510M 21.94B 1.61B 162M 145M 134M 122M 230M 15.35B 234M 632M 8.01B 608M 595M 25.62B
Net income 266M 26.64M 23.78M 22.1M 20.1M 37.82M 2.52B 38.51M 104M 1.32B 99.98M 97.86M 4.21B 328M 32.91M 29.38M 27.31M 24.84M 46.73M 3.12B 47.57M 128M 1.63B 124M 121M 5.2B
Net Debt 166M 16.66M 14.87M 13.82M 12.57M 23.65M 1.58B 24.08M 64.95M 823M 62.51M 61.19M 2.63B 33M 3.31M 2.96M 2.75M 2.5M 4.7M 314M 4.79M 12.91M 164M 12.43M 12.16M 524M
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
15/10/26 SEK 194.30 +0.62% 79,092
14/10/26 SEK 193.10 -0.41% 78,655
13/10/26 SEK 193.90 -0.10% 103,039
12/10/26 SEK 194.10 +1.20% 91,139
09/10/26 SEK 191.80 +3.51% 185,162
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
194.30SEK
Average target price
297.50SEK
Spread / Average Target
+53.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB
  1. Stock Market
  2. Stocks
  3. RAY B Stock